180 Life Sciences Corp. (NASDAQ: ATNF)
$2.0300
+0.0400 ( +2.01% ) 225.9K
180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research, and, where appropriate, combination therapy.
Market Data
Open
$2.0300
Previous close
$1.9900
Volume
225.9K
Market cap
$2.13M
Day range
$1.9310 - $2.3150
52 week range
$1.3100 - $14.1550
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 10-q | Quarterly Reports | 63 | Aug 12, 2024 |
| 8-k | 8K-related | 15 | Jul 30, 2024 |
| 8-k | 8K-related | 15 | Jul 23, 2024 |
| 8-k | 8K-related | 15 | Jul 02, 2024 |
| 8-k | 8K-related | 14 | May 21, 2024 |
| 8-k | 8K-related | 14 | May 15, 2024 |
| 10-q | Quarterly Reports | 62 | May 15, 2024 |
| 8-k | 8K-related | 20 | May 09, 2024 |
| 10-k/a | Quarterly Reports | 17 | Apr 29, 2024 |
| 8-k | 8K-related | 17 | Apr 19, 2024 |